Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_01690
Species: Homo sapiens
Position : chrX:153492724-153500546
Year: 2026
Title: Enhancer-mediated NR2F2 recruitment activates BGN to promote tumor growth and shape tumor microenvironment in papillary thyroid cancer.
Genome Build: hg38
Enhancer Type: Enhancer
Condition: Disease
Disease Name: thyroid gland carcinoma
PMID:  41328346
MONDO: MONDO:0015075
Tissue: thyroid gland
Tissue Ontology ID: UBERON:0002046
Cell Source: Thyroid carcinoma cell
Cell Type: malignant cell
Cell Ontology ID: CL:0001064
Experiment Type: Enhancer activity assay, TF binding assay, Chromatin interaction assay, Functional perturbation assay; Enhancer activity assay; Endogenous enhancer perturbation
High Throughput Method: ChIP-seq, RNA-seq; single-cell RNA-seq; RNA-seq
Low Throughput Method: Luciferase Reporter Assay, ChIP-RT-qPCR, CRISPRi, 3C assay, RT-RT-qPCR, Western blot; CRISPRi; Luciferase reporter assay; Flow cytometry
About Target Gene
Target gene : BGN
About TF
TF name : NR2F2
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
NR2F2 FOXA1 transcription factor network pid 45
NR2F2 Regulation of Telomerase pid 70
NR2F2 Transcriptional regulation of white adipocyte differentiation reactome 79
NR2F2 Hs_White_fat_cell_differentiation_WP3946_90940 wikipathways 30
Enhancer Associated Network
Overlapping Enhancers (hg38)
No overlapping enhancers found in hg38 at this locus.
Expression of Target Genes for the Enhancer